Amicus Therapeutics told investors during a recent conference about its plan to shift manufacturing of the drug from China to Ireland
Trump has long had the Chinese and Irish pharmaceutical sectors in his crosshairs. Photo: Getty Images
US drugmaker Amicus Therapeutics plans to move production of a rare medicine from China to Ireland to avoid any hit from tariffs threatened by US President Donald Trump.
Amicus Therapeutics, a producer of drugs for rare diseases, told investors during a recent conference about its plan to shift production of the medicine from China to Ireland.
source